←
Dale Shepard MD, PhD5,195 posts
Dale Shepard MD, PhD avatar

Dale Shepard MD, PhD

@ShepardDale

Director International Programs, Cleveland Clinic Cancer Institute and Co-Director Cleveland Clinic Sarcoma program. My opinions are mine.

◷ Joined December 2013▧ 344 Photos and videos
NEJM avatar
⟳ Dale Shepard MD, PhD retweeted
NEJM@NEJM·Feb 25

In a phase 1 study of the oral p53 reactivator rezatapopt in heavily pretreated patients with TP53 Y220C–mutated solid tumors, the most common adverse events were nausea and vomiting, and the overall response was 20%. Full PYNNACLE study results: nej.md/3OIQC5P Science behind the Study: Restoring Function to a Variant of p53 in Solid Tumors nej.md/3N0pQW8

Post attachment
Katie Ryba avatar
⟳ Dale Shepard MD, PhD retweeted
Katie Ryba@KatieRyba·4 Oct 2024

Listen to @CleClinicMD, Cancer Advances’ 200th episode featuring Dr. Greg Videtic! Dr. Videtic joins @ShepardDale to discuss neuroprotection in small-cell lung cancer patients and key findings from the NRG CC003 trial. cle.clinic/4eu45Xn #CleClinicCancer #200thepisode

Ofer Reizes avatar
⟳ Dale Shepard MD, PhD retweeted
Ofer Reizes@oreizes·26 Sep 2024

Honored to join @RobertoVargasMD to discuss our findings on targeting CD55 to combat chemoresistance in #gyncsm on the latest episode of Cancer Advances hosted by @ShepardDale. #CleClinicCancer cle.clinic/3BlCTeN thanks to all our collaborators @CCLRI @ClevelandClinic.

HemOnc Today avatar
⟳ Dale Shepard MD, PhD retweeted
HemOnc Today@HemOncToday·30 Aug 2024

Use of pembrolizumab with radiation therapy and surgery improved outcomes for certain patients with soft tissue sarcoma. Read the full story, plus expert perspective from @ShepardDale @CleClinicMD @Merck #Keytruda #immunotherapy healio.com/news/hematology-o…

Katie Ryba avatar
⟳ Dale Shepard MD, PhD retweeted
Katie Ryba@KatieRyba·23 Aug 2024

On the @CleClinicMD, Cancer Advances podcast this week, Dr. Lily Wang joins @ShepardDale to discuss how targeting VISTA & LRIG1 interactions could revolutionize treatment for resistant tumors. #Immunotherapy #CleClinicCancer cle.clinic/4dSsk0C

Jame Abraham, MD, FACP avatar
⟳ Dale Shepard MD, PhD retweeted
Jame Abraham, MD, FACP@jamecancerdoc·21 Aug 2024

Congratulations @ShepardDale and thank you for your dedication to educating doctors and public about cancer @ClevelandClinic @CleClinicMD !!

This morning we celebrated our 200th episode of the @CleClinicMD Cancer Advances podcast. Special thanks to our amazing host @ShepardDale editor Bill and my amazing colleague @KatieRyba who runs the podcast like a well oiled machine! #clecliniccancer

Post attachment
Nicole Marie avatar
⟳ Dale Shepard MD, PhD retweeted
Nicole Marie@italgal22·8 Aug 2024

@LukasDelasos joins @ShepardDale on Cancer Advances #podcast this week to discuss exciting advancements in #SCLC treatment. Listen as they discuss ongoing research & clinical trials to find better ways to manage this aggressive cancer. #CleClinicCancer cle.clinic/3YxvAtW

Jame Abraham, MD, FACP avatar
⟳ Dale Shepard MD, PhD retweeted
Jame Abraham, MD, FACP@jamecancerdoc·30 Jun 2024

Please support #CancerResearch @ClevelandClinic @bikeVeloSano !

These are stories written by @bikevelosano Bike to Cure participants whose lives have been impacted by cancer. We envision a future with new stories of cures, better treatments, and lives well-lived. To get involved ➡️ velosano.org #togethertocure

0:45
Thejus Jayakrishnan avatar
⟳ Dale Shepard MD, PhD retweeted
Thejus Jayakrishnan@ThejusJay·17 May 2024

Dr. Khorana discusses research exploring microbiome alterations in individuals with young or early-onset colorectal cancer @aakonc @ShepardDale #microbiome my.clevelandclinic.org/podca… via @clevelandclinic